NCT05229679Recruiting
HPV-based Screening Among Women 23-29 Years of Age
Evaluation of Organized Human Papilloma Virus (HPV) Screening of 23-29-year-old Women
Source: ClinicalTrials.gov · Last updated 19 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The aim of the trial is to determine whether organized screening with primary HPV analysis provide higher cancer protection in the age group 23-29 years compared to primary cytology.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 180000 (estimated)
- First submitted
- 30 Nov 2021
- Start date
- Nov 2020
- Primary completion date
- Dec 2038
- Lead sponsor
- Karolinska Institutet
- Diseases
- Cervical cancer
- NCT number
- NCT05229679
What you commit to
- Study type: Interventional
- Planned participants: 180000
- From Nov 2020 to the primary completion date, Dec 2038
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Women who do not show up for screening or do not consent.
Who the study is looking for
- Women ages 23-29 invited to screening.
Age in the registry: 23 years to 29 years · Sex: Female · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Region of Skåne Coordinator of this site? Confirm its status | Lund | Sweden | Active, not recruiting |
| Region Stockholm Coordinator of this site? Confirm its status | Stockholm | Sweden | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.